Fursova A Zh, Vasil'eva M V, Derbeneva A S, Tarasov M S, Chubar N V, Nikulich I F, Gusarevitch O G
Novosibirsk State Medical University, Novosibirsk, Russia.
Novosibirsk State Region Hospital, Novosibirsk, Russia.
Vestn Oftalmol. 2021;137(3):97-104. doi: 10.17116/oftalma202113703197.
One distinctive pathological sign of chronic kidney disease (CKD) is microcirculatory disorders, which mark it as a microvascular disease. Similarity in the blood supply of the retina and kidneys, in the anatomy of their vascularization lead to identical complications in these organs. The retinal-choroidal microvascular system is easily accessible for clinical and morphological assessment and can be examined by the reproducible and non-invasive method - optical coherence tomography (OCT) and OCT angiography (OCTA). The study of significant diagnostic tomographic retinal biomarkers in CKD and monitoring of their changes are of great clinical importance. The article presents clinical cases of changes in the retina and choroid depending of the stage of CKD. Retinal microvascular changes precede functional impairment. A significant decrease in retinal and choroidal thickness correlates with a decrease in the glomerular filtration rate (GFR) and the degree of albumin excretion in the urine. All clinical cases were observed to exhibit retinal microcirculation disorders, capillary rarefaction in both capillary plexuses accompanied by a decrease in vessel density and a decrease in the circularity index of the foveal avascular zone as a result of regression of the parafoveal capillary networks. OCTA allowed visualization of morphological changes at the microcirculatory level in the form of blunt ends of capillaries, their increased tortuosity and the presence of local areas of decreased perfusion. The severity of retinal microvascular changes varied depending on the stage of CKD and was not associated with either age or the presence of diabetes mellitus. Assessment of the retinal microvasculature can help with monitoring of microvascular lesions, early prediction of the risk of development and progression of decreased renal function, as well as allow avoiding aggressive diagnostic biopsy.
慢性肾脏病(CKD)的一个显著病理特征是微循环障碍,这使其成为一种微血管疾病。视网膜和肾脏在血液供应以及血管化解剖结构上的相似性导致这些器官出现相同的并发症。视网膜 - 脉络膜微血管系统易于进行临床和形态学评估,可通过可重复且无创的方法——光学相干断层扫描(OCT)和 OCT 血管造影(OCTA)进行检查。研究 CKD 中有重要诊断价值的视网膜断层生物标志物并监测其变化具有重大临床意义。本文介绍了根据 CKD 分期视网膜和脉络膜变化的临床病例。视网膜微血管变化先于功能损害出现。视网膜和脉络膜厚度的显著降低与肾小球滤过率(GFR)降低及尿白蛋白排泄程度相关。所有临床病例均观察到视网膜微循环障碍,两个毛细血管丛均出现毛细血管稀疏,伴有血管密度降低以及由于黄斑旁毛细血管网络消退导致的黄斑无血管区圆形度指数降低。OCTA 能够以毛细血管钝端、其迂曲度增加以及存在局部灌注降低区域的形式可视化微循环水平的形态变化。视网膜微血管变化的严重程度因 CKD 分期而异,且与年龄或糖尿病的存在无关。评估视网膜微血管有助于监测微血管病变、早期预测肾功能下降发生和进展的风险,还能避免进行有创的诊断性活检。